Pfizer Receives ₹85.74 Crore Income Tax Demand

Pfizer Ltd received an Income Tax assessment order dated April 23, 2026, demanding ₹85.74 crore for FY 2022-23.
The tax authority issued a show cause notice for initiating penalty proceedings under sections 274 and 270A of the Income Tax Act.
The demand is based on alleged under-reporting of income due to disallowance of expenses in the filed return.
The company states it will appeal the order and does not expect a material financial impact at this stage.